Cargando…
Focus on a 2019-novel coronavirus (SARS-CoV-2)
A new coronavirus, severe acute respiratory syndrome coronavirus 2, was first discovered in Wuhan, China, in December 2019. As of April 7, 2020, the new coronavirus has spread quickly to 184 countries and aroused the attention of the entire world. No targeted drugs have yet been available for interv...
Autores principales: | Zhang, Ling-Pu, Wang, Meixian, Wang, Yanping, Zhu, Jun, Zhang, Nannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291595/ https://www.ncbi.nlm.nih.gov/pubmed/32524843 http://dx.doi.org/10.2217/fmb-2020-0063 |
Ejemplares similares
-
The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
por: Zhu, James, et al.
Publicado: (2020) -
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020) -
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020) -
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020) -
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
por: Xu, Xi, et al.
Publicado: (2020)